Literature DB >> 20618812

Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS).

Andrew Blumenfeld1, Avi Ashkenazi, Brian Grosberg, Uri Napchan, Samer Narouze, Bob Nett, Traci DePalma, Barbara Rosenthal, Stewart Tepper, Richard B Lipton.   

Abstract

BACKGROUND: Many clinicians use peripheral nerve blocks (NBs) and trigger point injections (TPIs) for the treatment of headaches. Little is known, however, about the patterns of use of these procedures among practitioners in the USA.
OBJECTIVES: The aim of this study was to obtain information on patterns of office-based use of peripheral NBs and TPIs by headache practitioners in the USA.
METHODS: Using an Internet-based questionnaire, the Interventional Procedures Special Interest Section of the American Headache Society (AHS) conducted a survey among practitioners who were members of AHS on patterns of use of NBs and TPIs for headache treatment.
RESULTS: Electronic invitations were sent to 1230 AHS members and 161 provided usable data (13.1%). Of the responders, 69% performed NBs and 75% performed TPIs. The most common indications for the use of NBs were occipital neuralgia and chronic migraine (CM), and the most common indications for the use of TPIs were chronic tension-type headache and CM. The most common symptom prompting the clinician to perform these procedures was local tenderness at the intended injection site. The most common local anesthetics used for these procedures were lidocaine and bupivacaine. Dosing regimens, volumes of injection, and injection schedules varied greatly. There was also a wide variation in the use of corticosteroids when performing the injections. Both NBs and TPIs were generally well tolerated.
CONCLUSIONS: Nerve blocks and TPIs are commonly used by headache practitioners in the USA for the treatment of various headache disorders, although the patterns of their use vary greatly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618812     DOI: 10.1111/j.1526-4610.2010.01676.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

1.  Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients?

Authors:  Hanzade Aybüke Ünal-Artık; Levent Ertuğrul İnan; Ceyla Ataç-Uçar; Tahir Kurtuluş Yoldaş
Journal:  Neurol Sci       Date:  2017-02-28       Impact factor: 3.307

2.  Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.

Authors:  Christina L Szperka; Amy A Gelfand; Andrew D Hershey
Journal:  Headache       Date:  2016-10-12       Impact factor: 5.887

3.  Effectiveness of Greater Occipital Nerve Blocks in Migraine Prophylaxis.

Authors:  Nurten Inan; Levent E Inan; Özlem Coşkun; Tuğba Tunç; Mustafa Ilhan
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

4.  Elective Hospitalizations for Intractable Headache: Outcomes and Response Predictors.

Authors:  Jessica Kiarashi; Yasmin Jion; Brandon Giglio; Jelena Pavlovic; Cynthia E Armand; Brian M Grosberg; Richard B Lipton; Sarah Vollbracht; Matthew S Robbins
Journal:  Neurol Clin Pract       Date:  2021-06

5.  A Randomized, Double-Dummy, Emergency Department-Based Study of Greater Occipital Nerve Block With Bupivacaine vs Intravenous Metoclopramide for Treatment of Migraine.

Authors:  Benjamin W Friedman; Eddie Irizarry; Andrew Williams; Clemencia Solorzano; Eleftheria Zias; Matthew S Robbins; Melissa A Harrilal; Michael Del Valle; Polly E Bijur; E John Gallagher
Journal:  Headache       Date:  2020-09-27       Impact factor: 5.887

Review 6.  Peripheral Nerve Blocks for Postdural Puncture Headache: A New Solution for an Old Problem?

Authors:  Luca Gregorio Giaccari; Caterina Aurilio; Francesco Coppolino; Maria Caterina Pace; Maria Beatrice Passavanti; Vincenzo Pota; Pasquale Sansone
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

7.  A new look at trigger point injections.

Authors:  Clara S M Wong; Steven H S Wong
Journal:  Anesthesiol Res Pract       Date:  2011-09-29

8.  An Association between Carpal Tunnel Syndrome and Migraine Headaches-National Health Interview Survey, 2010.

Authors:  Huay-Zong Law; Bardia Amirlak; Jonathan Cheng; Douglas M Sammer
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-04-07

9.  Topographic Relationship between the Supratrochlear Nerve and Corrugator Supercilii Muscle--Can This Anatomical Knowledge Improve the Response to Botulinum Toxin Injections in Chronic Migraine?

Authors:  Hyung-Jin Lee; Kwang-Seok Choi; Sung-Yoon Won; Prawit Apinuntrum; Kyung-Seok Hu; Seong-Taek Kim; Tanvaa Tansatit; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

10.  Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation.

Authors:  Francesca Puledda; Peter J Goadsby; Prab Prabhakar
Journal:  J Headache Pain       Date:  2018-01-16       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.